ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NBRV Nabriva Therapeutics PLC

1.42
0.00 (0.00%)
Pre Market
Last Updated: 20:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.53M8.59M8.99M9.25M8.02M9.41M9.51M10.57M
Operating Income -13.45M-11.03M-10.68M-12.89M-11.56M-10.18M-10.85M-22.33M
Pre Tax Income -13.79M-11.15M-10.9M-13.12M-11.47M-10.69M-10.99M-22.47M
Net Income -13.98M-11.75M-10.65M-13.06M-11.82M-11.07M-11.51M-22.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -13.57M-10.91M-10.68M-12.89M-11.25M-10.18M-10.85M-22.33M
EBITDA -13.18M-10.83M-10.6M-12.81M-11.48M-10.11M-10.81M-22.31M
Year End December 30 2022 20152016201720182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.77M6.54M5.81M9.66M9.7M6.21M29.36M37.51M
Operating Income -27.76M-54.99M-73.28M-114.65M-79.27M-64.94M-48.06M-54.92M
Pre Tax Income -47.41M-55.56M-73M-114.73M-82.66M-69.35M-48.96M-55.62M
Net Income -46.96M-54.89M-74.36M-114.78M-82.76M-69.48M-49.45M-57.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -22.195-20.18-2.026-1.713-0.875-3.296-0.872-17.865
EBIT -28.16M-54.99M-73.28M-114.65M-79.27M-67.7M-48.06M-54.92M
EBITDA -27.61M-54.76M-72.84M-114.14M-78.5M-64.12M-47.42M-54.7M

Your Recent History

Delayed Upgrade Clock